Oxford Cannabinoid Technologies Holdings Plc Stock
Equities
OCTP
GB00BMVMRB86
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.205 GBX | +10.22% | +32.26% | -67.20% |
May. 17 | Oxford Cannabinoid says it remains bound by Takeover Code | AN |
May. 08 | Oxford Cannabinoid shares plummet following delisting request | AN |
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 2.02M 2.57M |
---|---|---|---|---|---|
Net income 2024 * | -2M -2.54M | Net income 2025 * | -3M -3.81M | EV / Sales 2024 * | - |
Net cash position 2024 * | 1.18M 1.5M | Net Debt 2025 * | 2.03M 2.57M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.85
x | P/E ratio 2025 * |
-0.64
x | Employees | 7 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 70.17% |
1 day | +3.33% | ||
1 week | +20.00% | ||
Current month | -48.33% | ||
1 month | -46.86% | ||
3 months | -57.24% | ||
6 months | -71.38% | ||
Current year | -70.24% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 44 | - | |
Paul Smalley
DFI | Director of Finance/CFO | - | 22-10-16 |
Chief Tech/Sci/R&D Officer | 55 | 20-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | - | |
Julie Pomeroy
CHM | Chairman | 69 | - |
Timothy Corn
CTO | Chief Tech/Sci/R&D Officer | 73 | 23-06-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-24 | 0.205 | +10.22% | 7 134 511 |
24-05-23 | 0.186 | +3.33% | 27,544,820 |
24-05-22 | 0.18 | +2.86% | 14,628,510 |
24-05-21 | 0.175 | +29.63% | 30,369,970 |
24-05-20 | 0.135 | -12.90% | 25,994,820 |
Delayed Quote London S.E., May 23, 2024 at 11:35 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-70.24% | 2.57M | |
+64.92% | 62.86B | |
-1.85% | 41.38B | |
+44.76% | 40.38B | |
-8.93% | 27.64B | |
+13.05% | 26.46B | |
-21.96% | 18.9B | |
+4.21% | 12.67B | |
+25.74% | 12.27B | |
+27.42% | 12.07B |
- Stock Market
- Equities
- OCTP Stock